{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:49:41Z","timestamp":1792748981712,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005378","name":"Hacettepe Universitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brazilian Journal of Otorhinolaryngology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bjorl.2021.02.009","type":"journal-article","created":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T01:11:01Z","timestamp":1615684261000},"page":"968-974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lysyl Oxidase Like-4 (LOXL4) as a tumor marker and prognosticator in advanced stage laryngeal cancer"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8747-7420","authenticated-orcid":false,"given":"Ozan Muzaffer","family":"Altunta\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9901-3044","authenticated-orcid":false,"given":"Nilda","family":"S\u00fcsl\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9365-3534","authenticated-orcid":false,"given":"Ye\u015fim Gaye","family":"G\u00fcler Tezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4318-2775","authenticated-orcid":false,"given":"Hayriye","family":"Tatl\u0131 Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8999-3237","authenticated-orcid":false,"given":"Taner","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjorl.2021.02.009_bib0005","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMra0707975","article-title":"Recent advances in head and neck cancer","volume":"359","author":"Haddad","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0010","author":"Howlader"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0015","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0025","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1002\/lary.24933","article-title":"Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma","volume":"125","author":"Bernstein","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0030","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nature04695","article-title":"Lysyl oxidase is essential for hypoxia-induced metastasis","volume":"440","author":"Erler","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1055-9965.EPI-08-0347","article-title":"Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium","volume":"18","author":"Hashibe","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0040","first-page":"4567","article-title":"LOXL4 as a selective molecular marker in primary and metastatic head\/neck carcinoma","volume":"30","author":"Scola","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0045","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1566524033479447","article-title":"Molecular mechanisms of tumor invasion and metastasis: an integrated view","volume":"3","author":"Cairns","year":"2003","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0050","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrc3621","article-title":"bHLH-PAS proteins in cancer","volume":"13","author":"Bersten","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0055","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1158\/0008-5472.CAN-04-1543","article-title":"Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers","volume":"64","author":"Kaneda","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0060","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1158\/0008-5472.CAN-06-3867","article-title":"The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2\/neu-driven breast cancer","volume":"67","author":"Min","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/path.2137","article-title":"Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma","volume":"212","author":"Gorogh","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/coa.12498","article-title":"Differential expression of LOXL4 in normal and tumour tissue samples of laryngeal squamous cell carcinoma","volume":"41","author":"Yilmaz","year":"2016","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0075","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1371\/journal.pmed.0030047","article-title":"Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers","volume":"3","author":"Chi","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0080","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1158\/1078-0432.CCR-13-0542","article-title":"A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer","volume":"19","author":"Eustace","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0085","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ejca.2008.03.026","article-title":"LOXL4 is a selectively expressed candidate diagnostic antigen in head and neck cancer","volume":"44","author":"Weise","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0090","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1158\/0008-5472.CAN-07-0012","article-title":"LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras\/extracellular signal-regulated kinase signaling pathway in human bladder cancer","volume":"67","author":"Wu","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0095","first-page":"317","article-title":"Vaccination strategy to target lysyl oxidase-like 4 in dendritic cell based immunotherapy for head and neck cancer","volume":"32","author":"Weise","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bjorl.2021.02.009_bib0100","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/ijc.29986","article-title":"Lysyl oxidase like-4 monoclonal antibody demonstrates therapeutic effect against head and neck squamous cell carcinoma cells and xenografts","volume":"138","author":"Gorogh","year":"2016","journal-title":"Int J Cancer"}],"container-title":["Brazilian Journal of Otorhinolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869421000549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869421000549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:38:20Z","timestamp":1761723500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1808869421000549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1808869421000549"],"URL":"https:\/\/doi.org\/10.1016\/j.bjorl.2021.02.009","relation":{},"ISSN":["1808-8694"],"issn-type":[{"value":"1808-8694","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysyl Oxidase Like-4 (LOXL4) as a tumor marker and prognosticator in advanced stage laryngeal cancer","name":"articletitle","label":"Article Title"},{"value":"Brazilian Journal of Otorhinolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjorl.2021.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Associa\u00e7\u00e3o Brasileira de Otorrinolaringologia e Cirurgia C\u00e9rvico-Facial. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}